Canagliflozin is an Inhibitor drug for SGLT2. It can lower blood glucose levels by expelling the glucose from the body through the kidneys after its decomposition. In addition, Canagliflozin has a broad prospect due to its significant antiobesity effects and few hypoglycemic events.
Canagliflozin is a selective sodium-glucose cotransporter 2 (SGLT2) inhibitor used in pharmaceutical manufacturing. Its molecular formula is C28H25NO6S and CAS No. is 849291-03-8. The core synthesis involves glycosylation and coupling reactions under strict GMP conditions.
Contraindicated in severe renal impairment or dialysis patients. Store in a cool, dry place below 25°C away from moisture. Handle with appropriate PPE to avoid inhalation or skin contact during powder processing.